Diflu 50 mg/5 ml (Powder for Suspension)

35 ml bottle: ৳ 78.00

Medicine Details

Indications

  • Vaginal Candidiasis
  • Oropharyngeal Candidiasis
  • Oesophageal Candidiasis
  • Tinea corporis/Tinea cruris/Tinea pedis/Other Tinea
  • Kerion
  • Pityriasis versicolor
  • Onychomycosis
  • Invasive candidal infections and cryptococcal infections (including meningitis)
  • Prevention of cryptococcal meningitis
  • Prevention of fungal infections in immunocompromised patients
  • Systemic Candidiasis and Cryptococcal infection
  • Superficial Candidiasis
  • Fungal urinary tract infections
  • Disseminated candidiasis
  • Prophylaxis for fungal infection in neutropenic cancer patients
  • Acute treatment of other systemic fungal infections such as coccidioidomycosis and histoplasmosis

Pharmacology

  • Triazole antifungal agent
  • Inhibitor of fungal cytochrome P-450 dependent enzymes
  • Potent inhibitor of cytochrome P-450 enzyme system responsible for ergosterol synthesis

Dosage & Administration

  • Adult dosage for various indications
  • Child dosage for Superficial Candidiasis and Systemic Candidiasis & Cryptococcal infection
  • Dosage adjustments for Elderly patients and Renal Impairment
  • Dosage modifications based on creatinine clearance levels

Interaction

  • Potential interactions with warfarin, sulfonylureas, hydrochlorothiazide, phenytoin, rifampicin, oral contraceptives, cyclosporin, theophylline
  • Impact of food, cimetidine, antacids, and irradiation on absorption
  • Monitoring recommendations for theophylline levels

Contraindications

  • Hypersensitivity to Fluconazole or related triazole compounds

Side Effects

  • Common gastrointestinal symptoms
  • Rare occurrence of rash
  • Anaphylaxis in rare cases

Pregnancy & Lactation

  • Adverse fetal effects observed in animals at high doses
  • Recommendation against use in pregnancy or women of childbearing potential without adequate contraception

Precautions & Warnings

  • Abnormalities in hepatic, renal, and biochemical function tests
  • Rare occurrences of hepatic necrosis
  • Exfoliative cutaneous reactions
  • Caution in use during lactation
  • Unlikelihood of impairment in driving or machinery operation

Use in Special Populations

  • Dosage adjustments for Elderly patients and Renal Impairment
  • Excretion mainly via urine
  • Dosage modifications based on creatinine clearance
  • Recommendation for monitoring cyclosporin levels

Overdose Effects

  • Supportive and symptomatic treatment
  • Potential use of gastric lavage
  • Elimination increase with diuresis
  • Haemodialysis impact on plasma levels

Therapeutic Class

  • Drugs for subcutaneous and mycoses

Storage Conditions

  • Dry place away from light and heat
  • Keep out of the reach of children

Related Brands